Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Researchers Desai et al. identify persistent barriers that prevent medication‑assisted treatment (MAT) for opioid use disorder from being fully integrated into specialty programs. Stigma toward patients and providers, restrictive regulations, and insufficient clinician training limit the use of proven drugs such as buprenorphine and methadone. Financial constraints and logistical challenges further impede access, while interdisciplinary collaboration and policy reform are proposed as solutions. The study calls for data‑driven advocacy to reshape treatment landscapes and improve recovery outcomes.
UC San Diego, backed by a $25.8 million ARPA‑H grant, is developing a 3‑D bioprinting platform to create patient‑specific, functional human livers. The multidisciplinary team combines rapid light‑based printing with AI‑driven vascular design to fabricate complex, multi‑cellular tissue in seconds. Partnering...
Protagonist Therapeutics faces a pivotal choice on its rusfertide partnership with Takeda. The company is leaning toward opting out of the 50‑50 co‑development deal, which would trigger a $400 million opt‑out payment and tiered royalties up to 29% on sales exceeding...
Establishing a secure supply chain now starts with early, cross‑functional purchasing controls. Development, quality, and procurement teams must collaborate to define requirements, qualify suppliers, and create quality agreements before scale‑up. The Parenteral Drug Association’s upcoming ANSI/PDA Standard 001‑2020 formalizes these expectations...
At Pharmapack Europe 2026, SÜDPACK Medica introduced its next‑generation PharmaGuard blister line, a mono‑material polypropylene solution that replaces multi‑layer composites with a recyclable, phthalate‑free film, now available in an opaque white version for better dosage readability. The company also launched...
Sandoz, Novartis' generics arm, announced plans to launch a generic version of Ozempic (semaglutide) in 2026. The move aligns with the anticipated expiration of Novo Nordisk's patents on the GLP‑1 drug, opening the U.S. and European markets to lower‑priced alternatives....
Novo Nordisk's oral Wegovy pill recorded 3,071 prescriptions within its first four days on the U.S. market, a figure that excludes sales through its NovoCare direct‑to‑consumer channel. The launch arrives as Eli Lilly awaits an FDA decision on its own oral...
The J.P. Morgan Healthcare Summit in San Francisco highlighted a surge in radiopharmaceutical development, positioning precision radiation therapy as a key growth area in oncology. AI‑driven molecular profiling is accelerating biomarker discovery and drug design, while the GLP‑1 market expands with...
Sanofi is reportedly preparing a renewed takeover bid for US‑based Ocular Therapeutix after its initial $16‑per‑share offer was rejected last summer. Ocular, valued at roughly $2.4 billion with shares trading around $11.28, is poised to file for approval of Axpaxli, a...
Novo Nordisk is revamping its business‑development approach under new CEO Mike Maziar Doustdar, emphasizing intentional M&A and licensing to accelerate its obesity and diabetes pipeline. The company recently closed a $5.2 billion acquisition of Akero Therapeutics and secured a China partnership...
Komodo Health announced Amit Sangani as its new chief technology officer, tasked with steering the AI‑native Marmot platform. Sangani arrives after an 11‑year tenure at Meta, where he led large‑scale AI systems including PyTorch and Llama, and previously co‑founded MightyText....
The New York Attorney General sued former Emergent BioSolutions CEO Robert Kramer for alleged insider trading, claiming he sold stock based on nonpublic knowledge of vaccine contamination. Kramer reportedly profited over $10.1 million from trades executed between November 2020 and early 2021....
The Wellcome‑funded Synthetic Human Genome (SynHG) project has launched a £10 million, five‑year effort to develop scalable technologies for building synthetic human chromosomes. The consortium of five UK universities aims to create the first fully synthetic human genome, tackling challenges from...
SPT Labtech has launched validated automated workflows for Twist Bioscience’s next‑generation sequencing (NGS) library preparation kits on its firefly® liquid handling platform. The initial offering supports the FlexPrep™ UHT kit and integrates the Twist Enzymatic Fragmentation Kit 2.0, delivering higher‑throughput,...
Korro Bio’s lead RNA‑editing candidate KRRO‑110 failed its Phase I/IIa trial for alpha‑1 antitrypsin deficiency, prompting an 80% stock plunge and a one‑third staff layoff. A root‑cause analysis revealed the lipid nanoparticle delivery vehicle achieved only about 25% of the...
The Mega-Fund Math vs Reality Below is a simple case study on fund math. People are asking if a16z can really do a 3-5x on a $15B fund. To 3x net on $15B, you need ~$45B back. Assume ~5% ownership at exit. 👉 That...
The European Medicines Agency (EMA) recommended 104 medicines for approval in 2025, marking the second‑highest total in the past 15 years. Of those, 38 are classified as novel drugs, a figure that trails the U.S. Food and Drug Administration (FDA)...
Ocugen reported that its phase‑2 ArMaDa trial of the gene therapy OCU410 achieved a 46% reduction in geographic atrophy lesion growth for medium and high doses, with the medium dose showing a 54% reduction. The data also revealed a 60%...
Novo Nordisk and BioMarin announced strategic partnerships to integrate artificial intelligence into their drug discovery pipelines, aiming to accelerate candidate identification and reduce development costs. Novo Nordisk highlighted a collaboration with a leading AI firm to model peptide therapeutics, while...
A meta‑analysis of 17 randomized controlled trials involving 739 older adults found that resistance exercise modestly improves overall cognitive function (SMD = 0.40). Significant gains were observed in working memory (SMD = 0.44), verbal learning (MD = 3.01), and spatial memory span (SMD = 0.63), while processing speed,...
Researchers at Mass General Brigham unveiled an autonomous, agentic AI system that scans routine clinical notes to flag early cognitive impairment. The platform, built from five specialized LLM agents, demonstrated 98% specificity and 91% sensitivity in balanced testing, though real‑world...
EDETEK Inc. unveiled Ensemble, an AI‑managed service that operationalizes validated, human‑supervised artificial intelligence across the clinical development lifecycle. The offering combines best‑fit large language and multimodal models, agentic automation, and domain experts to deliver production‑grade outputs such as SAP, SDTM,...
Scientists at University College London identified epoxy‑oxylipins as natural brakes that curb chronic inflammation by limiting intermediate monocyte expansion. In a human trial, the soluble epoxide hydrolase inhibitor GSK2256294 boosted epoxy‑oxylipin levels, accelerated pain resolution and lowered monocyte counts, though...
A recent qualitative study of Chinese psychiatric nurses reveals a nuanced stance toward artificial intelligence in mental‑health care. Nurses largely view AI as a supportive tool that can automate routine tasks and enhance decision‑making, yet they voice strong concerns about...
Researchers at the University of York identified a bacterial‑like gene in the plant Flueggea suffruticosa that drives production of the potent alkaloid securinine, revealing that plants can co‑opt microbial enzymes for chemical defense. This discovery shows the gene family is...
Labiotech‑EU hosted a special podcast where journalists Jules Adam, Roohi Peter and Willow Shah‑Neville each highlighted five biotech firms they expect to shape 2026, creating a curated list of 15 companies. The selections span gene‑therapy, immunology, neuroscience and platform technologies, featuring names such...
A qualitative study published in BMC Geriatrics explores how emergency‑department patients experience frailty screening. Researchers interviewed older adults to capture feelings ranging from anxiety about being labeled frail to relief at receiving tailored care. The findings highlight how the hectic...
The U.S. Centers for Disease Control and Prevention recently trimmed the routine childhood vaccine schedule, dropping three previously recommended immunizations—hepatitis A, hepatitis B, and rotavirus—reducing the total from 18 to 11 vaccines. The change aligns the U.S. schedule more closely with Denmark’s...
A new study introduces csRNA‑seq, a high‑resolution method that captures active RNA Polymerase II transcription start sites across the genome. The technique isolates short, capped RNAs, enabling precise mapping of promoter activity without requiring chromatin immunoprecipitation. Early validation in human...
A recent pre‑clinical study demonstrated that restoring the enzyme fructose‑1,6‑bisphosphatase 1 (FBP1) in diabetic mice markedly improves erectile function. The researchers used a targeted gene‑therapy approach to re‑express FBP1 in penile tissue, which rescued nitric oxide signaling and vascular responsiveness. Treated...
1/ The Back Door Is Open How Acute Infection Could Make Anti-Infectives Investable Again Anti-infectives never died. The business model did. Low prices. Short courses. High resistance risk. Pharma walked. Now look at Alfasigma stepping into HSV encephalitis. Small deal. Narrow indication. Big implication....
A vaccine to prevent colon cancer. Proof-of-concept for strong immune response and safety via neoantigens given to people with mutations for Lynch syndrome https://t.co/EfXDlTJlIz https://t.co/RtxfB4oGZ1
The study introduces PLASTIQ, a proximity‑ligation assay that quantifies intact DNA origami structures in vivo with single‑helix resolution. Using ligatable staple pairs, the method detects intact nanostructures from as little as 1 µl of blood, achieving a 0.01 fM detection limit. PLASTIQ...
1/ A 2010 Science paper claimed they'd found genetic variants strongly tied to living past 100. New York Times covered it. Media went wild. One problem: The results were wrong.
1/ Bioinformatics isn't just code. Intuition plays an important role too. You run the stats, but you feel when something’s wrong. That feeling is a clue. https://t.co/pV5SxvYuFL
Agenus finalized a $141 million strategic collaboration with Zydus Lifesciences to accelerate development and potential commercialization of its botensilimab‑balstilimab (BOT+BAL) immunotherapy combo. The deal grants Zydus exclusive rights to develop and sell BOT and BAL in India and Sri Lanka, while...
My latest Biotech Scorecard newsletter, post #JPM26 edition. JPM Week 2026 is over. It was fantastic. Here’s why https://t.co/uwgz7J4WRk
In #oncology #M&A higher 5-yr forward revenue multiples occur for earlier stage companies, though P3 is an exception Recently multiples have declined reflecting lower valuations, later stage acquisitions, and smaller market opportunities What are some other reasons? #learnbiotechinvesting #biotech #investing #BiotechPrometheus
Recent research uncovers how lipid droplets (LDs) dynamically interact with mitochondria, endoplasmic reticulum, and lysosomes, reshaping our understanding of intracellular lipid management. High‑resolution live‑cell imaging shows rapid LD‑organelle contact formation that regulates energy production, lipid synthesis, and autophagic turnover. The...
#AI-generated sensors open new paths for early cancer detection by Anne Trafton @MIT Learn more: https://t.co/udkbd5V4cP #MedTech #Healthcare #HealthTech #Tech #TechForGood https://t.co/0SpKlYQsVA
Currently approved CD19 CAR-T therapies extend lymphoma patient survival for years. These treatments are basically curative. Available right now for patients. On the other hand, experimental NK cell therapies have never worked because the cells aren’t persistent. @DrPatrick acts like...
Japan’s National Institutes for Quantum Science and Technology (QST) published a perspective in ACS Nano outlining how quantum tools—nanoscale biosensors, hyper‑polarized MRI, and quantum‑biology‑inspired catalysts—can shift life‑science from niche labs to routine clinical and industrial use. The roadmap highlights diamond‑based nitrogen‑vacancy...
Which modality has the cleanest path to durable clinical value over the next 5 years?
The J.P. Morgan Healthcare Conference ignited a surge of financing, the strongest in years for biotech. In a special BioCentury This Week podcast recorded at the conference, analysts and investors examined Asia’s burgeoning biotech ecosystems. Discussions covered deal pricing in China, the...
The article forecasts that the United States will adopt a most‑favored‑nation (MFN) drug‑pricing model, tying domestic prices to international reference benchmarks. Policymakers view MFN as a tool to curb soaring prescription costs, while industry groups warn it could compress profit...
Researchers have synthesized a series of quinoxalinyl and quinolinyl derivatives targeting the ALK5 kinase, a key driver of fibrotic signaling. In biochemical assays, several compounds achieved sub‑micromolar potency and demonstrated high selectivity against related TGF‑β receptors. Cellular studies showed these...
Washington University researchers identified enzyme copy‑number fluctuations as the primary source of metabolic noise in engineered E. coli producing the yellow pigment betaxanthin. By combining microfluidic single‑cell tracking with a bright‑fluorescent metabolite, they observed rapid switches between high‑ and low‑production states....
New York Attorney General sued the former chief executive of Emergent BioSolutions, alleging he engaged in insider trading while the company grappled with contamination problems at its Baltimore plant that delayed AstraZeneca’s COVID‑19 vaccine production. Prosecutors claim the executive sold...
How does obesity lead to immune system dysregulation and chronic inflammation? Macrophage metabolism is rewired, with activation of the NLRP3 inflammasome @ScienceMagazine https://t.co/bkAUgOE1c2 https://t.co/It6YaXT1b5
Swiss biotech TECregen announced seed financing to launch a pipeline of biologic drugs aimed at regenerating the aged thymus. The company’s “thymopoietics” are engineered growth‑factor molecules designed to rebuild thymic epithelial cells, the niche essential for T‑cell maturation. By concentrating...
